Senate Confirms Dr. Marty Makary as FDA Commissioner in Bipartisan Vote

Makary's confirmation signals a shift in FDA leadership with plans for reforms in food policy, vaccine advisory processes, and addressing pharmaceutical conflicts of interest.

Dr. Marty Makary was confirmed as FDA Commissioner in a 56-44 Senate vote, with three Democrats crossing party lines to support the nomination.
Makary, a Johns Hopkins professor and former Fox News medical contributor, has been a vocal critic of past FDA leadership and advocates for agency reforms.
During his confirmation hearings, Makary emphasized the need to address food-related health issues, including childhood obesity and early-onset Alzheimer's.
He pledged to review vaccine advisory processes and ensure transparency in drug and vaccine regulation, responding to concerns raised during the hearings.
Makary's confirmation aligns with the Trump administration's 'Make America Healthy Again' agenda, focusing on decentralization, innovation, and restoring trust in public health institutions.